These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 38727312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients.
    Hernigou P, Dubory A, Homma Y, Guissou I, Flouzat Lachaniette CH, Chevallier N, Rouard H.
    Int Orthop; 2018 Jul; 42(7):1639-1649. PubMed ID: 29744647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Implantation of Culture-Expanded Bone Marrow Derived Mesenchymal Stromal Cells for Treatment of Osteonecrosis of the Femoral Head.
    Yoon SD, Shim BJ, Baek SH, Kim SY.
    Tissue Eng Regen Med; 2024 Aug; 21(6):929-941. PubMed ID: 38877362
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.
    Mao Q, Jin H, Liao F, Xiao L, Chen D, Tong P.
    Bone; 2013 Dec; 57(2):509-16. PubMed ID: 23994171
    [Abstract] [Full Text] [Related]

  • 8. Core Decompression Combined with Implantation of Autologous Bone Marrow Concentrate with Tricalcium Phosphate Does Not Prevent Radiographic Progression in Early Stage Osteonecrosis of the Hip.
    Hernandez A, Nuñez JH, Sallent A, Gargallo-Margarit A, Gallardo-Calero I, Barro V.
    Clin Orthop Surg; 2020 Jun; 12(2):151-157. PubMed ID: 32489535
    [Abstract] [Full Text] [Related]

  • 9. Culture-Expanded Autologous Adipose-Derived Mesenchymal Stem Cell Treatment for Osteonecrosis of the Femoral Head.
    Yoon PW, Kang JY, Kim CH, Lee SJ, Yoo JJ, Kim HJ, Kang SK, Min JH, Yoon KS.
    Clin Orthop Surg; 2021 Mar; 13(1):37-46. PubMed ID: 33747376
    [Abstract] [Full Text] [Related]

  • 10. Cell therapy of hip osteonecrosis with autologous bone marrow grafting.
    Hernigou P, Poignard A, Zilber S, Rouard H.
    Indian J Orthop; 2009 Jan; 43(1):40-5. PubMed ID: 19753178
    [Abstract] [Full Text] [Related]

  • 11. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells.
    Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, Liu B, Yu X.
    Bone; 2012 Jan; 50(1):325-30. PubMed ID: 22094904
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair?
    Hernigou P, Guerin G, Homma Y, Dubory A, Chevallier N, Rouard H, Flouzat Lachaniette CH.
    Int Orthop; 2018 Jul; 42(7):1739-1745. PubMed ID: 29796764
    [Abstract] [Full Text] [Related]

  • 14. Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results.
    Calori GM, Mazza E, Colombo M, Mazzola S, Mineo GV, Giannoudis PV.
    Injury; 2014 Feb; 45(2):369-73. PubMed ID: 24119830
    [Abstract] [Full Text] [Related]

  • 15. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study.
    Rastogi S, Sankineani SR, Nag HL, Mohanty S, Shivanand G, Marimuthu K, Kumar R, Rijal L.
    Musculoskelet Surg; 2013 Dec; 97(3):223-8. PubMed ID: 23852661
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells.
    Persiani P, De Cristo C, Graci J, Noia G, Gurzì M, Villani C.
    Acta Orthop Belg; 2015 Sep; 81(3):406-12. PubMed ID: 26435234
    [Abstract] [Full Text] [Related]

  • 18. Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial.
    Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y.
    Clin Orthop Relat Res; 2020 Jun; 478(6):1307-1315. PubMed ID: 31899739
    [Abstract] [Full Text] [Related]

  • 19. Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.
    Lebouvier A, Poignard A, Coquelin-Salsac L, Léotot J, Homma Y, Jullien N, Bierling P, Galactéros F, Hernigou P, Chevallier N, Rouard H.
    Stem Cell Res; 2015 Nov; 15(3):584-594. PubMed ID: 26492634
    [Abstract] [Full Text] [Related]

  • 20. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis.
    Wang Z, Sun QM, Zhang FQ, Zhang QL, Wang LG, Wang WJ.
    Int J Surg; 2019 Sep; 69():23-31. PubMed ID: 31301432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.